Biomea Fusion Inc (BMEA)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$2.03+6.28%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · BMEA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||
| R&D Expenses | 40.8 | 62.0 | 118.1 | 102.5 | 62.7 | 28.0 | 3.7 |
| Operating Income | (58.1) | (83.5) | (144.1) | (126.1) | (83.6) | (41.7) | (5.3) |
| Earnings from Continuing Operations | |||||||
| Asset Writedown | — | 2.2 | — | 0.0 | — | — | — |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||
| Net Income | (32.5) | (61.8) | (138.4) | (117.3) | (81.8) | (41.6) | (5.3) |
| Per Share | |||||||
| Basic EPS | (0.45) | (1.18) | (3.83) | (3.44) | (2.80) | (1.74) | (0.51) |
| Diluted EPS | (0.45) | (1.18) | (3.83) | (3.44) | (2.80) | (1.74) | (0.51) |
| Basic Weighted Avg Shares | 72.4 | 52.2 | 36.1 | 34.1 | 29.3 | 23.9 | 10.5 |
| Diluted Weighted Avg Shares | 72.4 | 52.2 | 36.1 | 34.1 | 29.3 | 23.9 | 10.5 |
| Supplemental | |||||||
| EBIT | (58.1) | (83.5) | (144.1) | (126.1) | (83.6) | (41.7) | (5.3) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.